Nelipepimut-S

Nelipepimut-S, an advanced peptide-based immunotherapeutic intervention, has demonstrated significant efficacy within the biomedical sector as it pertains to breast cancer management. Acting with precision, it selectively engages HER2-positive malignancies, thereby amplifying and fortifying the immune system's retaliation against these deleterious cells.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: R2072

CAS No:160212-35-1

Synonyms/Alias:NELIPEPIMUT-S;Neuvax;160212-35-1;NeuVax vaccine;KIFGSLAFL;Nelipepimut-S [USAN];E75 peptide;UNII-7M0A29CD8B;7M0A29CD8B;DTXSID80166835;L-Leucine, L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl-;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid;Nelipepimut-S (USAN);L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl-L-leucine;Human receptor tyrosine-protein kinase erbB-2 (proto-oncogene Neu, tyrosine kinase- type cell surface receptor HER2, CD340)-(347-355)-peptide;Nelipepimut s;E75 HER2 peptide;E-75 PEPTIDE;10: PN: WO2015050181 SEQID: 10 claimed protein;CHEMBL386200;NELIPEPIMUT S [WHO-DD];DTXCID3089326;AHOKKYCUWBLDST-QYULHYBRSA-N;CHEBI:230310;Her2 369-377;BDBM50409332;AKOS040753235;DA-76075;E-75;HER-2/NEU PEPTIDE (369-377);HY-106204;CS-0025241;Q27268544;HUMAN RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2 (PROTO-ONCOGENE NEU, TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2, CD340)-(347-355)-PEPTIDE;

Chemical Name:(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C50H78N10O11
M.W/Mr.
995.2
Sequence
One Letter Code:KIFGSLAFL
Three Letter Code:H-Lys-Ile-Phe-Gly-Ser-Leu-Ala-Phe-Leu-OH
InChI
InChI=1S/C50H78N10O11/c1-8-31(6)42(60-44(64)35(52)21-15-16-22-51)49(69)58-37(25-33-17-11-9-12-18-33)45(65)53-27-41(62)55-40(28-61)48(68)57-36(23-29(2)3)46(66)54-32(7)43(63)56-38(26-34-19-13-10-14-20-34)47(67)59-39(50(70)71)24-30(4)5/h9-14,17-20,29-32,35-40,42,61H,8,15-16,21-28,51-52H2,1-7H3,(H,53,65)(H,54,66)(H,55,62)(H,56,63)(H,57,68)(H,58,69)(H,59,67)(H,60,64)(H,70,71)/t31-,32-,35-,36-,37-,38-,39-,40-,42-/m0/s1
InChI Key
AHOKKYCUWBLDST-QYULHYBRSA-N
Canonical SMILES
CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCCCN)N
Isomeric SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServiceEpitope Mapping ServicesPeptide Analysis ServicesPeptide CDMOCustom Conjugation ServicePeptide Synthesis ServicesPeptide Nucleic Acids SynthesisPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers